Inventor
RYDE NIELS P
US19 patents
⚠️ This page may combine multiple inventors who share the name “RYDE NIELS P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ELAN PHARMA INT LTD
9 patentsUS6592903B2Jul 15, 2003
Nanoparticulate dispersions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
ELAN PHARMA INT LTD216 citations99
US6375986B1Apr 23, 2002
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
ELAN PHARMA INT LTD349 citations99
US6969529B2Nov 29, 2005
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
ELAN PHARMA INT LTD69 citations98
US7459283B2Dec 2, 2008
Nanoparticulate compositions having lysozyme as a surface stabilizer
ELAN PHARMA INT LTD38 citations96
US7198795B2Apr 3, 2007
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
ELAN PHARMA INT LTD62 citations95
US7763278B2Jul 27, 2010
Nanoparticulate polycosanol formulations and novel polycosanol combinations
ELAN PHARMA INT LTD42 citations92
US7244451B2Jul 17, 2007
Methods of making nanoparticulate drug compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
ELAN PHARMA INT LTD17 citations92
US7695739B2Apr 13, 2010
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions
ELAN PHARMA INT LTD6 citations71
US7998507B2Aug 16, 2011
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
ELAN PHARMA INT LTD6 citations56
ALKERMES PHARMA IRELAND LTD
6 patentsUS9345665B2May 24, 2016
Reduction of flake-like aggregation in nanoparticulate active agent compositions
ALKERMES PHARMA IRELAND LTD13 citations91
US11717481B2Aug 8, 2023
Reduction of flake-like aggregation in nanoparticulate active agent compositions
ALKERMES PHARMA IRELAND LTD2 citations72
US11253478B2Feb 22, 2022
Reduction of flake-like aggregation in nanoparticulate active agent compositions
ALKERMES PHARMA IRELAND LTD1 citations72
US9974746B2May 22, 2018
Reduction of flake-like aggregation in nanoparticulate active agent compositions
ALKERMES PHARMA IRELAND LTD2 citations72
US9974748B2May 22, 2018
Reduction of flake-like aggregation in nanoparticulate active agent compositions
ALKERMES PHARMA IRELAND LTD1 citations61
US9974747B2May 22, 2018
Reduction of flake-like aggregation in nanoparticulate active agent compositions
ALKERMES PHARMA IRELAND LTD1 citations61